You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Chile Patent: 2017000979


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Chile Patent: 2017000979

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,385,078 Nov 10, 2035 Takeda Pharms Usa ALUNBRIG brigatinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Chile Patent CL2017000979

Last updated: July 29, 2025

Introduction

Patent CL2017000979, granted in Chile, pertains to a pharmaceutical invention. As with all patents, its scope and claims define the boundaries of patent protection, and understanding these elements is fundamental for stakeholders — pharmaceutical companies, patent attorneys, and competitors. This analysis explores the patent’s scope, claims, and its position within the broader patent landscape, providing insights for strategic decision-making.

Background and Patent Context

Chile’s patent law aligns broadly with international standards, including those of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). The Chilean patent system allows for pharmaceutical patents, provided they meet criteria such as novelty, inventive step, and industrial applicability. Patents for drugs typically cover innovative formulations, methods of use, or manufacturing processes.

Patent CL2017000979 was filed with the Intellectual Property Office of Chile (INAPI) in 2017, suggesting it relates to a novel pharmaceutical composition or method. Understanding its precise scope involves dissecting its claims, which legally define the extent of protection.

Scope of Patent CL2017000979

The scope of this patent is detailed and pivotal since it delineates what is protected and what remains open for competitors. It is primarily determined by the claims, which articulate the patent's boundaries.

Analysis of Patent Claims

Independent Claims

The core protection is often provided by independent claims, which stand alone without dependence on other claims. A typical independent claim in a pharmaceutical patent might describe:

  • A novel compound or composition,
  • A specific method of preparation,
  • A therapeutic use of a composition.

In patent CL2017000979, the main independent claim likely covers a specific chemical entity or a pharmaceutical formulation, possibly combined with a novel delivery method or therapeutic indication.

For example:
"A pharmaceutical composition comprising [active ingredient(s)] in a therapeutically effective amount, optional excipients, wherein the composition exhibits [specific property or effect]."

Implication: This claim would broadly cover formulations containing the active ingredient and its therapeutic use, securing protection over similar compositions with minor variations.

Dependent Claims

Dependent claims refine or specify particular embodiments, such as:

  • Specific dosage forms (e.g., tablets, capsules, injections);
  • Particular excipients or stabilizers;
  • Manufacturing conditions or processes;
  • Specific therapeutic indications or uses.

These claims narrow the scope but enhance patent robustness by covering multiple variations, making infringement more difficult.

Scope Assessment

Given the typical structure, the scope likely encompasses a specific chemical compound or class, its pharmaceutical formulations, and methods of use for treating certain conditions. The breadth depends on language particularity — broad if using generic terms, narrow if specifying precise chemical structures.

Limitations: The scope is limited by prior art, especially if similar compounds or formulations exist. Chile’s patentability standards require that claims demonstrate inventive step over existing technology.

Patent Landscape Analysis

Global Context

Pharmaceutical patents operate within an international framework, often with overlapping protections. Key considerations include:

  • Patent family and priority data:
    The applicant may have filed in other jurisdictions, such as PCT applications, indicating global patent strategies.

  • Related patents:
    Similar patents in other jurisdictions could impact enforceability and freedom-to-operate.

Chile-Specific Patent Landscape

Chile's patent system, while harmonized with international norms, has unique features:

  • The patent term is 20 years from the filing date.
  • Prior art searches are rigorous, especially for chemical and biological inventions.

Competitive Landscape:
A search indicates that related patents exist in the global patent databases, notably in regions like the US, Europe, and Asia, covering similar compounds and uses. Chile’s patents often mirror or build upon these prior arts, but with localized claims tailored to the Chilean market.

Key Patent Documents for Comparative Analysis

  • International filings: Possible PCT family members may provide insight into the invention's scope and claimed advantages.
  • Pre-existing drugs: Patents on similar compounds or formulations could impact the scope's scope and scope of inventive step.

Legal and Patentability Considerations

  • The patent’s validity may hinge on demonstrating an inventive step over known compounds or formulations.
  • Chilean patent law emphasizes industrial applicability; thus, the claimed invention must demonstrate practical utility.

Claim Scoping and Enforcement Implications

Broader claims afford more extensive exclusivity but risk invalidation if challenged on novelty or inventive step. Narrower claims may limit scope but are easier to defend.

In practice, patentees should consider:

  • The specificity of chemical structures or uses claimed.
  • Potential design-around strategies by competitors.
  • The importance of dependent claims to secure protection for alternative embodiments.

Patent Landscape Strategies and Challenges

  • Prior art navigation: Understanding existing patents is crucial to avoid infringement and ensure novel claim drafting.
  • Patent prosecution: Strategic claim amendments during examination can balance scope and validity.
  • Freedom-to-operate (FTO): Due diligence reveals whether similar patents restrict commercial launch in Chile.

Conclusion

Patent CL2017000979 appears to encompass a specific pharmaceutical formulation or compound, with claims likely covering a defined chemical entity, preparation method, and therapeutic application. Its scope is shaped by the precise language of its claims, carefully balanced to maximize protection while maintaining validity under Chilean patent law.

The patent operates within a complex landscape comprising both local and global patent protections. Competitors and patentees should analyze related patents to assess infringement risks and potential for licensing or invalidation.

Key Takeaways

  • Precise Claim Drafting: Clear, specific claims enhance enforceability and reduce invalidation risk.
  • Landscape Awareness: Monitoring related patents informs strategic decisions and innovation pathways.
  • Broader versus Narrow Claims: Broader claims increase market exclusivity but carry higher validity risks; narrower claims are safer but limit coverage.
  • Global Strategy: Patents in Chile often link to international patent families, enabling expansion or consolidation of protection.
  • Legal Vigilance: Regular patent landscape analyses and legal assessments are essential to safeguard market rights and avoid infringement.

FAQs

Q1: What is the significance of the claims in patent CL2017000979?
A1: Claims define the legal scope of protection; they specify the invention's boundaries, determining what competitors cannot legally make, use, or sell without permission.

Q2: How does Chile’s patent law impact pharmaceutical patent protection?
A2: Chile requires patents to demonstrate novelty, inventive step, and industrial applicability, aligning with international norms. Patent protection is generally 20 years from filing.

Q3: Can similar patents in other jurisdictions affect the enforceability of CL2017000979?
A3: Yes. Prior art from other countries can challenge patent validity or limit the scope if similar inventions are already known, impacting enforcement.

Q4: What strategies can patentees use to strengthen the scope of their pharmaceutical patent?
A4: Precise, well-drafted claims covering various embodiments, and filing related patents in multiple jurisdictions, help broaden protection and mitigate design-around risks.

Q5: How does the patent landscape influence R&D investment in pharmaceuticals?
A5: A robust patent landscape offers insights into existing protections and gaps, guiding R&D focus, licensing opportunities, and market entry strategies.

References

[1] INAPI. Chilean Patent Official Gazette; Patent CL2017000979.
[2] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
[3] Chilean Patent Law No. 19,039.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.